期刊文献+

非经典型21羟化酶缺陷症的研究进展 被引量:2

Nonclassic 21-hydroxylase deficiency
原文传递
导出
摘要 非经典型21羟化酶缺陷症是21羟化酶缺陷症中酶活性下降较轻的一种类型。其临床表现缺乏特异性,往往仅有轻度雄激素过多症状和体征;常混杂于高雄激素血症的其他病因中,与多囊卵巢综合征的临床特征相近,易于漏诊或误诊。因其发病率高,且常合并胰岛素抵抗及其他代谢紊乱,正日益受到人们重视。本文着重从其临床特征、分子遗传学特点、诊断与治疗等方面进行系统地阐述。 Nonclassic type of congenital adrenal hyperplasia (NCAH) is caused by mild defect of 21 hydroxylasc activities resulting from CYP21A2 gene mutation. Its phenotype is usually considered as hyperandrogen related disorders, such as polycystic ovarian syndrome and frequently misdiagnosed. NCAH is becoming a major problem due to its higher incidence and accompanied with insulin resistance and other metabelic disorders. We systematically discuss the clinical features, molecular genetics, diagnosis and therapy of this disease.
出处 《国际内分泌代谢杂志》 2007年第6期418-421,共4页 International Journal of Endocrinology and Metabolism
关键词 非经典型21羟化酶缺陷症 21羟化酶缺陷症 高雄激素血症 Nonclassic 21-hydroxylase deficiency 21-Hydroxylase deficiency Hyperandrogenism
  • 相关文献

参考文献20

  • 1Speiser PW, Dupont B, Rubinstein P, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet, 1985, 37:650-667.
  • 2Romaguera J, Moran C, Diaz-Montes TP, et al. Prevalence of 21- hydroxylase deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. Fertil Steril,2000, 74:59-62.
  • 3Therrell BL,Adams J. Newborn screening in North America. J Inherit Metab Dis,2007,30:447-465.
  • 4Baumgartner-Parzer SM, Nowotny P, Heinze G, et al. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab, 2005,90:775-778.
  • 5Loidi L, Quinteiro C, Parajes S, et al. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect. Clin Endocrinol (Oxf),2006, 64:330-336.
  • 6张波,陆召麟,王玥,陶红.非经典型21-羟化酶缺乏症基因型和临床特征[J].中华内分泌代谢杂志,2005,21(1):43-46. 被引量:13
  • 7Araujo RS, Mendonca BB, Barbosa AS, et al. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab, 2007,92:4028-4034.
  • 8Barbaro M, Lajic S, Baldazzi L, et al. Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab, 2004,89:2402-2407.
  • 9Lajic S,Clauin S,Robins T,et al. A novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab ,2002,87:2824-2829.
  • 10Glintborg D, Hermann AP, Brusgaard K, et al. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, Caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab,2005,90: 1347-1353.

二级参考文献8

  • 1White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev, 2000,21:245-291.
  • 2Asanuma A, Ohura T, Ogawa E, et al. Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency. J Hum Genet, 1999,44:312-317.
  • 3Yokoyama Y, Teraoka M, Tsuji K, et al. Rapid screening method to detect mutation in CYP21, the gene for 21-hydroxylase. Am J Med Genet, 2000,94:28-31.
  • 4Balsamo A, Cacciari E, Baldazzi L, et al. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region. Clin Endocrinol, 2000,53:117-125.
  • 5Weintrob N, Brautbar C, Pertzelan A, et al. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. Eur J Endocrinol, 2000,143:397-403.
  • 6Tajima T, Fujieda K, Nakae J, et al. Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan. Endocr J, 1998,45:493-497.
  • 7Moran C, Azziz R, Carmina E, et al. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol, 2000,183:1468-1474.
  • 8Blanche H, Vexiau P, Clauin S, et al. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet, 1997,101:56-60.

共引文献12

同被引文献27

  • 1张波,陆召麟,王玥,陶红.非经典型21-羟化酶缺乏症基因型和临床特征[J].中华内分泌代谢杂志,2005,21(1):43-46. 被引量:13
  • 2Sinclair AH, Berta P, Palmer MS, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif[ J ]. Nature, 1990,346:240 - 244.
  • 3Lee PA, Houk CP, S. Ahmed, F et al. Consensus Statement on Management of Intersex Disorders[J]. Pediatric ,2006,118:488 - 500.
  • 4Merke DP, Bornstein SR. Congenital adrenal hyperplasia [ J ]. Lancet, 2005,365 ( 9477 ) :2125 - 2136.
  • 5Nimkarn S, Lin-Su K, New MI. Steroid 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia [ J ]. Endocrinol Metab Clin N Am,2009,38(4) :699 -718.
  • 6Zhang HJ, Yang J, Zhang MN et al. Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21- hydroxylase deficiency [ J ]. Endocrine,2010,38 ( 2 ) :260 - 265.
  • 7Zhang H J, Yang J, Zhang MN et al. Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency[J], Clin Endocrinol (Oxf) ,2009,70 (2) :201 - 207.
  • 8Yang J, Cui B, Sun S et al. Phenotype-genotype con'elation in eight Chinese 17 alpha-hydroxylase/17, 20 lyase-deficiency patients with five novel mutations of CYP17A1 gene[J]. J Clin Endocrinol Metab,2006,91 (9) :3619 -3625.
  • 9张惠杰,杨军,顾生虹,张炜,刘建民,宁光,李小英.新复合杂合突变致非经典型21-羟化酶缺陷症[J].中华内分泌代谢杂志,2007,23(5):396-399. 被引量:4
  • 10Jaresch S, Kornely E, Kley HK, et al. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia [ J ] . J Clin Endocrinol Metab, 1992, 74 ( 3 ) : 685-689.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部